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632 A. Leri et al.IntroductionHistorically, the foundations of the concept that the heart is
a static organ incapable of regeneration were established in
the mid-1920s. A significant publication in 1925 claimed that
mitotic figures are not detectable in human cardiomyocytes
(Karsner et al., 1925), which were considered as cells
irreversibly withdrawn from the cell cycle. This work
challenged numerous studies published from 1850 to 1911
in which the general belief was that cardiac hypertrophy was
the consequence of hyperplasia and hypertrophy of existing
cardiomyocytes (for review see Anversa and Kajstura, 1998).
The 1925 report introduced the notion that the heart is a
terminally differentiated post-mitotic organ.
The conclusion that new cardiomyocytes cannot be formed
in the human heart was mostly dictated by difficulties in
identifying mitotic nuclei. The conviction that the pool of
myocytes present at birth is irreplaceable during the lifespan
of the organism gained further support from a series of
autoradiographic studies conducted in the late 1960s and early
1970s (Anversa and Kajstura, 1998; Soonpaa and Field, 1998).
The degree of DNA synthesis in myocyte nuclei was negligible,
and this observation, together with the inability to distinguish
mitotic images in cardiomyocytes, reiterated the theory
that the adult heart is composed of a homogenous population
of parenchymal cells that are in a permanent state of growth
arrest.
However, quantitative measurements of myocyte volume
and number, performed in human hearts collected from
patients who died as a result of decompensated cardiac
hypertrophy and chronic heart failure, began to challenge
this concept of myocardial biology. In the late 1940s and
early 1950s, Linzbach documented that, in the presence of a
heart weight equal to or greater than 500 g, myocyte
proliferation represented the predominant mechanism of
the increase in cardiac muscle mass (Linzbach, 1947, 1960).
These results were confirmed several years later (Adler and
Friedburg, 1986; Astorri et al., 1971, 1977). In all cases,
hearts weighing 500 g or more were characterized by a
striking increase in myocyte number that was more promi-
nent than cellular hypertrophy; this adaptation involved the
left and right ventricular myocardium.
An inherent inconsistency became apparent. If we assume
that cardiomyocytes lack the ability to reenter the cell cycle
and replicate, differences in myocyte size would be
expected to reflect comparable differences in the size of
the organ. However, changes in heart weight and cardio-
myocyte volume rarely coincide challenging the notion that
the number of myocytes is an entity that remains constant
throughout the organ lifespan. This discrepancy has been
reported frequently with postnatal maturation, myocardial
aging and cardiac diseases (Anversa and Kajstura, 1998;
Anversa et al., 1998). Changes in myocyte number are the
consequence of two interrelated mechanisms, myocyte
death and myocyte formation. This rather simple biological
principle is often ignored; the plasticity of the myocardium
cannot be equated to myocyte hypertrophy only.
The critical interaction of cell death and cell renewal is not
unique to the heart. Organmass in prenatal and postnatal life is
determined by the balance between cell death and cell
division, which regulate the number of parenchymal cellswithin the tissue (Hipfner and Cohen, 2004). With various
diseases, cell loss may be compensated by an increase in size of
the surviving cells, although this response may become rapidly
maladaptive in view of the difficulty of hypertrophied cells to
perform efficiently their specialized function (Gomer, 2001).
Postnatal cardiac development, endurance exercise train-
ing, and pregnancy are typical examples of physiological
cardiac hypertrophy (Dorn, 2007; Hill and Olson, 2008).
The rapid expansion in myocardial mass after birth in
mammals involves both an increase in size and number of
cardiomyocytes, but the growth of the coronary vasculature
markedly exceeds the growth of the myocyte compartment
(Anversa and Olivetti, 2002; Rakusan et al., 1994). It is
difficult to compare the dramatic increase in heart weight
that occurs postnatally with the relatively modest degree of
cardiac hypertrophy promoted by dynamic exercise. Addition-
ally, there is little information concerning the cellular basis of
exercise- and pregnancy-induced myocardial hypertrophy.
Similarly, the mechanisms implicated in the regression
of cardiac hypertrophy with loss of physical conditioning, or
following delivery, have not been determined. Whether
new myocytes are formed with endurance exercise and
pregnancy and whether myocyte loss, myocyte atrophy, or
both, contribute to the restoration of myocardial mass with
cessation of exercise and pregnancy are unknown. Thus far,
the only conclusion that can be reached is that preservation of
myocardial structure characterizes postnatal development,
moderate endurance training, pregnancy, and the early
phases of increased pressure and volume loading on the
adult heart. This balanced “physiological” response, however,
is temporary, and aging, strenuous exercise, and sustained
workload lead to the structural and functional manifestations
of “pathological” hypertrophy, pointing to “time” as the
critical determinant of the transition from physiological to
pathological cardiac hypertrophy (Dorn, 2007).
An adequate regenerative outcome depends on the pres-
ence of exogenous and/or endogenous stem cells, or on the
existence of a pool of constantly cycling parenchymal cells.
Replicating myocytes are small in size and mononucleated,
suggesting that they might derive from: a) activation and
differentiation of stem/progenitor cells; and/or b) prolifera-
tion of pre-existing immature myocytes. Currently, there is
disagreement in the scientific community regarding the origin
and magnitude of cell regeneration occurring in the mamma-
lian heart. Labeling studies with thymidine analogs (Gonzalez
et al., 2008; Hosoda et al., 2009; Kajstura et al., 2010a)
and mathematical modeling of hierarchically structured cell
populations (Kajstura et al., 2010b) have both documented a
constant formation of new myocytes. Conversely, a minimal
contribution of cardiomyogenesis has been reported during
physiological aging in animals and humans (Bergmann et al.,
2009; Hsieh et al., 2007). The debate continues, and time will
tell whether the ability of the heart to renew itself is an
important variable or an inconsequential biological process of
cardiac homeostasis and repair.
Tissue-specific adult stem cells
Hematopoietic stem cells (HSCs) are the first tissue-specific
adult stem cells that have been described (Ema et al., 2014;
Scadden, 2014), so that stem cells in other organs are typically
studied based on the characteristics of these blood-forming
Figure 1 Bone marrow niches. A–C. Schematic representa-
tion of bone marrow niches. See text for detail.
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develop multilineage hematopoietic colonies in the spleen
(Siminovitch et al., 1963). In addition to the fundamental
attributes of self-renewal, clonogenicity andmultipotentiality,
HSCs have been defined as units of a hierarchically structured
system, in which stem cells give rise to oligolineage progenitors
that lose self-renewal properties and generate a progeny
of transient amplifying cells with restricted differentiation
potential.
It might be difficult today to imagine that the discovery
of HSCs was received with great skepticism, comparable to
that surrounding the documentation of cardiac stem cells
(CSCs). In the early 1970s, the possibility that HSCs existed
and regulated blood cell formation was not accepted. Bone
marrow stem cells were defined elusive or enigmatic and the
protocols employed for their identification were criticized
(Unlisted authors, 1971). In vivo bioassays consisted of
intravenous injection of unfractionated bone marrow cells
followed by the monitoring of colonies being generated in
the spleen (Chu-tse and Min-pei, 1984). By transplanting
progressively smaller numbers of marrow cells, the number
of colonies detected in the spleen was proportional to the
size of the inoculum, while the dimensions of the colonies
was proportional to the time post-inoculation (Boggs and
Boggs, 1973). These results were consistent with the
hypothesis that the spleen colonies were derived from single
cells. Moreover, the analysis of the cellular composition of
these colonies revealed that all blood cell types were
represented, supporting the multipotentiality of the founder
cell (Chu-tse and Min-pei, 1984). The spleen colony forming
cell, or CFU-S, was considered the definitive HSC.
Accumulating data, however, revealed that CFU-S missed
one of the fundamental stem cell properties: CFU-S could not
undergo long-term replication and asymmetric cell division
(Schofield, 1978; Schofield and Lajtha, 1983). These processes
emphasized an apparent inconsistency. On the one hand, the
long-term repopulating ability of bone marrow cells did not
decline significantly with age and, on the other, the bone
marrow-derived spleen colonies showed an “age-structure,”
which was evident in the serial transplantation assay and in
mice receiving chronic irradiation (Gaidul et al., 1986;
Schofield, 1978). Thus, Schofield concluded that the CFU-S is
not the ultimate HSC.
The true HSC was described as a cell that, upon isolation
and transplantation, forms spleen colonies, but resides in the
bonemarrow in association with one ormore cells, becoming a
“fixed tissue cell” (Schofield, 1978). The cellular environment
inhabited by stem cells was defined as “niche” (Schofield,
1978). In the niche, stem cells remain undifferentiated and
divide asymmetrically generating a daughter stem cell, which
is retained within the niche, and a daughter cell, which
corresponds to the first generation of colony-forming cells
(CFCs) (Unlisted authors, 1971). The latter retains a certain
degree of developmental plasticity and, in case of need, can
occupy an empty niche, becoming a fixed stem cell. The free
CFC undergoes a finite number of divisions. At each division,
the replicative capacity is reduced and progressivematuration
is acquired. After a given number of divisions, CFCs become
differentiated, representing a cell population that has an “age
structure” (Fig. 1A).
When the number of stem cells is reduced as a consequence
of damaging stimuli, physiological aging or following serialtransplantation in subsequent recipients, an incomplete filling
of the empty niches occurs (Albright and Makinodan, 1976;
Lajtha and Schofield, 1969). By introducing extra-divisions
during the maturation of the CFU-S, a compensatory response
for the maintenance of hematopoiesis is activated. Over time,
634 A. Leri et al.the proportion of CFU-S with long-term repopulating ability
declines and a progressively smaller number of niches are
occupied. The fourth transfer is incompatible with survival
because the cells formed in the last division have a very low
repopulating ability (Fig. 1B). These studies opened the field
of the biology of hematopoiesis (Morrison and Scadden, 2014;
Scadden, 2014; Suda et al., 2011).The niche: Stem cells and supporting cells
Stem cells are stored in niches, which are located deep in the
tissue for protection from damaging stimuli (Morrison and
Scadden, 2014; Scadden, 2014; Solanas and Benitah, 2013).
The niche constitutes a dynamic entity in which the control of
stem cell function depends on the complex interaction of
intrinsic and extrinsic factors. Stem cells are defined by their
behavior rather than by the specific genes that they express.
The set of genes that distinguishes stem cells from the early
committed cell progeny has not been determined as yet, and,
given the plasticity and heterogeneity of adult stem cells, a
“stemness identifier” may not exist (Fuchs and Chen, 2013).
Chemical and physical signals modulate the behavior of
stem cells. In addition to cytokines and cell surface adhesion
molecules, shear forces, oxygen tension, innervation, and
ions are major determinants of stem cell function (Spiegel et
al., 2008; Wang and Wagers, 2011). Cell-to-cell signaling and
a variety of effectors mediate the fate of stem cells within
the niches, promoting self-renewal or favoring their migra-
tion and differentiation. The bidirectional communication
between stem cells and supporting cells conditions the
characteristics of the niche, reflecting either a quiescent or
active state. A few examples of the mechanisms involved in
the regulation of stem cell growth are given. Initially, the
ability of the niche to preserve stemness was documented in
the Drosophila ovariole that contains two germline stem
cells (GSCs) surrounded by a group of differentiated somatic
cells, expressing Hedgehog and Wingless. The JAK-STAT
pathway ensures the renewal of GSCs by acting in concert
with the bone morphogenic protein (BMP). The BMP2/4
homolog decapentaplegic constitutes a relevant factor that
maintains female GSCs by inducing cell division (Xie and
Spradling, 1998). Similarly, Hedgehog controls the Hippo
pathway in the ovarian follicle stem cells where it preserves
their stemness and proliferation (Huang and Kalderon,
2014).
The niche in the bone marrow integrates multiple partic-
ipants (Zhang et al., 2003). The endosteal region is important
for hematopoiesis while the mature osteolineage cells
have an indirect role in modulating HSCs. The bone-forming
osteolineage cells result in high local concentrations of Ca2+,
and the Ca2+-sensing receptor promotes the engraftment
of HSCs (Adams et al., 2006). In the perivascular niche,
endothelial and mesenchymal stem cells, together with
sympathetic nerve fibers, modulate HSC behavior (Oh and
Kwon, 2010). A major regulator of stem cell function is the
Notch receptor system, which ensures a proper balance
between stem cells and their progeny by preventing or
favoring cell commitment. This lineage switch is apparent in
the skin where Notch inhibits the formation of epidermal
keratinocytes and promotes the generation of hair follicles
(Williams et al., 2011). Similarly, the effects of Notch on bonemarrow cells vary according to the state of maturation of the
stimulated cells. Synthesis of the Notch ligand Jagged1 by
osteoblasts increases the number of HSCs in the bone marrow
niches (Calvi et al., 2003). In contrast, Notch activation in
hematopoietic progenitors induces the formation of immune
cells (Radtke et al., 2013). In the brain, Notch signaling
expands the pool of immature precursors and enhances glial
formation (Androutsellis-Theotokis et al., 2006).Cardiac stem cell niches: A challenging task
The importance of the niche microenvironment for under-
standing HSC behavior was acknowledged shortly after
the discovery of this adult stem cell class. In the absence
of niches, the stemness of the primitive cells cannot be
preserved. Outside of their natural milieu, stem cells
acquire a high probability to differentiate, a process that
may lead to exhaustion of their compartment. This in vivo
condition is consistent with the high propensity of stem cells
to undergo lineage commitment in culture. A well-defined
growth medium supplemented with specific cytokines and
the presence of feeder layers are often required for the
maintenance of the undifferentiated state of stem cells.
More recently, attempts have been made to develop
artificial niches able to protect the immature stem cell
phenotype (Lee-Thedieck and Spatz, 2012; Tan and Barker,
2013).
Based on the knowledge acquired in the bonemarrow, CSCs
were expected to reside in myocardial niches. Our current
understanding of the biology of CSC niches is limited. Ten
years after the discovery of resident CSCs (Beltrami et al.,
2003), a PubMed search for “cardiac stem cell niche” yielded
only 137 articles. These reports recognize the relevance of
stem cell niches, but the large majority failed to address the
issues concerning their cellular composition, distribution in
the myocardium, changes in function with age and cardiac
diseases, and the molecular control of CSC growth and
differentiation.
For the systematic identification of stem cell niches,
specific criteria have to be fulfilled: stem cells have to be
recognized, the anchoring of stem cells to the supporting
cells determined, and the existence of an ancestor-progeny
relationship established. Because of the knowledge acquired
over the years on the properties of HSCs, the approaches
employed for the definition and characterization of bone
marrow HSC niches (Scadden, 2014) have been considered to
represent the ideal strategy for the analysis of the niche
microenvironment in the myocardium. However, the vari-
ables included in the study of HSCs and their milieu cannot
be translated without caveats to solid organs, including the
heart and its resident CSCs.
The bone marrow structure has facilitated the identifica-
tion of HSC niches and their function. The marrow is located
within the bone, in which osteoblasts form a well-defined
lining to which quiescent HSCs adhere (Nakamura et al., 2010;
Sugimura et al., 2012). The association between these two cell
types (Fig. 1C) makes the distribution of osteoblasts a valid
reference point for the recognition of HSC niches (Arai et al.,
2012). The technical limitations involving the assessment of
the spatial and temporal relationship of stem cells and their
niches in solid organs have been overcome in HSCs by dynamic
635Cardiac stem cell nichesconfocal imaging of the bone marrow underlying the skull
(Sipkins et al., 2005). The cortex of the mouse skull is
relatively thin and the visualization of HSCs can be achieved
with minimal manipulation (Lo Celso et al., 2011). Unique
anatomical regions characterized by specialized endothelium
have been identified, and the interactions between circulat-
ing and resident cells within the bone marrow have been
defined (Kunisaki and Frenette, 2014; Sipkins et al., 2005).
The possibility to ablate the niches and create empty
structures that can be repopulated has provided the bases
for prospective studies of HSCs. The bone marrow produces
blood cells that migrate continuously to the peripheral
circulation, constituting an unlimited source of differenti-
ated progeny. The availability of large numbers of commit-
ted cells and the opportunity to collect serial samples has
facilitated the retrospective analysis of the cells of origin
within the HSC niches and the documentation of abnormal
hematopoiesis when the structure of the niche is altered.
Similarly, the rapid self-renewal kinetics and the simple
and repetitive architecture of the intestinal epithelium have
favored its study as a primary system for the characterization
of adult stem cells. In each crypt, stem cell differentiation
proceeds orderly from the bottom to the luminal surface,
suggesting that the primitive cell compartment is located at
the base of the crypt. The possibility was advanced that stem
cells reside within a ring of 16 cells positioned immediately
above the Paneth cells (Potten, 1977; Potten and Loeffler,
1990). More recently, the columnar cells at the base of the
crypt have been considered as resident stem cells (Barker,
2014). Two distinct stem cell populations expressing specific
surface markers have been characterized, but whether both
models are correct, or one reflects more precisely the biology
of the intestine remains to be defined. Fatemapping strategies
have suggested that stem cell behavior is context dependent
and that the two stem cell classes may have separate
functions.
The myocardium lacks the basal–apical orientation typical
of epithelial organs making it difficult to delineate the precise
localization of CSC niches. The epicardial lining has been
employed to define anatomically several classes of niches in the
adult heart (Castaldo et al., 2008; Di Meglio et al., 2010a,
2010b; Kocabas et al., 2012; Limana et al., 2007, 2010; Smart
et al., 2011; Zhou et al., 2008). However, cardiac niches are not
limited to the subepicardium and are dispersed throughout the
myocardium (Urbanek et al., 2006). CSC niches are more
numerous in the atria and apex, which represent protected
anatomical areas characterized by low hemodynamic stress
(Boni et al., 2008; Goichberg et al., 2011; Gonzalez et al., 2008;
Hosoda et al., 2009; Sanada et al., 2014; Urbanek et al., 2006,
2010). The process of myocyte formation lacks directionality;
the scattered distribution of the sites of cardiomyogenesis
complicates the demonstration of the topography of cardiac
niches.
The analysis of cardiac niches becomes problematic if we
consider that the strategies used for the depletion of
bone marrow niches cannot be implemented in the heart.
The protocol of lethal and sub-lethal irradiation of the bone
marrow does not result in effective ablation of CSCs in
the myocardium, preventing the possibility of repopulating
empty niches with fluorescently labeled stem cells. Because
of its physical properties, the cardiac muscle is affected only
when 30 Gy units of absorbed radiation are utilized. Thisdose is more than 3-fold higher than that used in the bone
marrow and results in profound alterations of the myocar-
dium, diffuse myocyte apoptosis, and high animal mortality
(Leri et al., 2007).c-kit-positive cells and cardiac niches
To establish whether CSC niches are present in the myocar-
dium and whether CSC number is tightly regulated within the
niches, the young mouse heart was studied initially by a
morphometric approach (Urbanek et al., 2006). The niche was
defined as a randomly oriented ellipsoid structure constituted
by cellular and extracellular components (Fig. 2A). Within the
niches, lineage-negative CSCs are typically clustered together
with early committed cells, which continue to express the
c-kit receptor but show nuclear localization of the myocyte
transcription factor Nkx2.5 and cytoplasmic distribution of the
contractile protein α-sarcomeric actin (Fig. 2B). The number
of CSCs is higher in the atrial and apical myocardium than in
the base-mid-region of the young and old heart (Fig. 2C)
(Sanada et al., 2014; Urbanek et al., 2006).
The recognition of the anatomical localization of CSCs and
their distribution in the cardiac chambers was complemented
with functional studies, which were required for understand-
ing the growth kinetics of CSCs in vivo. The transplantation
assay, which involves the creation of tissue damage and the
injection of exogenous stem cells, is commonly employed.
CSCs engraft within the infarcted myocardium, expand their
pool and differentiate in cardiomyocytes and coronary vessels
(Bearzi et al., 2007; Beltrami et al., 2003; Ellison et al., 2014;
Fischer et al., 2009; Konstandin et al., 2013; Mohsin et al.,
2012; Smart et al., 2011;Williams et al., 2013). Additionally, a
large quantity of newly-formed undifferentiated CSCs can be
acquired and delivered to subsequent recipients forming both
primitive and specializedmuscle cells and vascular structures.
This methodology, however, leaves open the question
whether the properties displayed by the administered cells
are intrinsic to the stem cells or are influenced by the organ
injury.
Information concerning CSC function in the intact myocar-
dium involves labeling of resident stem cells with nucleotide
analogs or lentiviral fluorescent tags (Gonzalez et al., 2008;
Hosoda et al., 2009; Sanada et al., 2014; Urbanek et al., 2006).
The slow rate of proliferation of stem cells allows their
identification within their natural milieu and the evaluation of
their committed progeny (Braun et al., 2003). The administra-
tion of repeated doses of nucleotide analogs such as BrdU or 3
[H]-thymidine results in labeling of cycling cells (Braun et al.,
2003). These molecules are incorporated in the nuclei during
S-phase. A prolonged chase period leads to the dilution of the
label in cells that are rapidly replicating and its maintenance in
cells that are rarely or slowly cycling. Thus, the growth and
phenotypic changes occurring in CSCs during their transition
from an undifferentiated to a specialized compartment can be
characterized.
To identify the label-retaining cells within the myocardium,
BrdU was administrated and the intensity of the BrdU signal
was examined after a prolonged chasing period (Urbanek et al.,
2006). As expected, the number of bright BrdU-CSCs in the
atria decreased rapidly after chasing while the number of dim
BrdU-CSCs increased over time. The bright BrdU-CSCs detected
Figure 2 CSC niches. A. Schematic representation of the cellular and extracellular components of a CSC niche. B. Atrial (upper
panels) and ventricular (lower panels) niches at 7 days after birth composed of clusters of undifferentiated c-kit-positive CSCs
(green). Some of these cells express Nkx2.5 alone (white; arrows) or Nkx2.5 together with a thin layer of α-SA (red; arrows). C. The
number of CSCs per mm3 of myocardium increases with age in the atria, Base-MR and apex. M, months. *, **, †, §P b 0.05 vs. 3 M,
24 M, atria, base-MR, respectively. (Panel A from Leri et al., 2007; Leri et al., 2011; Panel B from Urbanek et al., 2010; Panel C from
Sanada et al., 2014).
636 A. Leri et al.
Figure 2 (continued).
637Cardiac stem cell nichesafter a chase period of 2–5 months (Fig. 2C) constitutes the
subset of slow-cycling stem cell pool in the atria. Similar
changes were seen in the base-mid-region and apex. The
aggregate number of CSCs remained constant throughout the
period of observation indicating that the growth kinetics of
CSCs tends to preserve the pool of primitive cells in the young
healthy heart (Urbanek et al., 2006). Thus, cardiac niches
harbor a subset of BrdU-retaining cells; these CSCs may
correspond to the category of undifferentiated cells that are
self-renewing, clonogenic andmultipotent in vitro (Beltrami et
al., 2003; Bearzi et al., 2007, 2009).
The BrdU pulse-chase protocol provides information on the
growth kinetics of the CSC population but does not allow the
recognition of the mechanism of CSC division at the single cell
level. Stem cells can divide symmetrically and asymmetrical-
ly. When stem cells engage themselves in asymmetric division,
one daughter-stem cell and one daughter-amplifying cell
are formed. When stem cells divide symmetrically, two
self-renewing daughter cells or two committed amplifying
cells are generated. In the young mouse heart, the homeosta-
sis of the cardiac niches is mediated by asymmetric and
symmetric division of CSCs (Urbanek et al., 2006). Asymmetric
division, however, is the predominant form of CSC replication;
it accounts for ~65% of proliferating CSCs. This mechanism of
cell renewal is termed “invariant” and typically occurs in
organs in a steady state (Watt and Hogan, 2000).
Recently, a lineage tracing study in the mouse has
challenged the implications that c-kit-positive cardiac
progenitors have in the modulation of myocyte turnover
and regeneration in the mammalian heart (van Berlo et al.,
2014), questioning the results obtained by fate mapping in
rodents (Ellison et al., 2014). There are several variables
that have to be considered in an effort to reconcile these
contrasting findings. There is no perfect experimental
strategy that can provide an undisputable answer to any
scientific question. Genetic manipulations have limitations
as any other methodology. The knock-in strategy employed
leads inevitably to the loss of one allele of the c-kit gene
which may affect significantly the physiological role of the
c-kit receptor and the ability of c-kit-positive CSCs to
proliferate and form a myocyte progeny (Nadal-Ginard et
al., 2014). This defect in c-kit receptor function may be
organ specific and the myocardium might have been more
severely affected than other organs, i.e., the bone marrow
and the lung. A good example consistent with this possibility
can be found in the discrepancy between the number of
cardiomyocytes derived from c-kit-positive CSCs in this
model that is in sharp contrast with the large formationof lung cells (van Berlo et al., 2014), an organ in which
c-kit-positive cells have been shown to regulate the growth
and differentiation of epithelial cells (Kajstura et al., 2011).
Sca1-positive cardiac progenitors are implicated in cardio-
myocyte formation in the mouse (Bailey et al., 2012; Uchida
et al., 2013), in which an almost 100% co-expression of c-kit
and Sca1 in CSCs was detected (Urbanek et al., 2005).
In contrast, Sca1-positive progenitors are not present in
large mammals and humans. Thus, data in mice cannot be
translated to human beings without caveats.
Cardiac niches contain lineage negative cells nested
together with cardiac progenitors and precursors. In close
proximity to lineage negative cells, myocytes and fibroblasts
are commonly visible. Within the niches, stem cells are
connected to the supporting cells by gap and adherens
junctions composed of connexins and cadherins, respective-
ly. The recognition that junctional complexes are present
between CSCs and myocytes or fibroblasts suggests that
these cell types act as supporting cells within the cardiac
niches. Conversely, endothelial cells and smooth muscle
cells do not exert this role. On this basis, the cross-talk
between CSCs and cardiomyocytes and fibroblasts has been
carefully documented by a series of in vitro assays, which
have provided strong evidence in favor of the functional
coupling of these three cell populations; the transfer of dyes
via gap junction channels between CSCs and cardiomyocytes
or fibroblasts was shown by multiple protocols (Bearzi et al.,
2009; Urbanek et al., 2006). Additionally, the translocation
of microRNA-499 from cardiomyocytes to CSCs may occur
physiologically resulting in lineage specification of CSCs and
myocyte formation (Hosoda et al., 2011).Cardiac niches and the Notch receptor system
The Notch pathway is an evolutionary conserved intercellular
and intracellular mechanism that controls stem cell fate
(Bray, 2006). The Notch gene family encodes transmembrane
receptors that are activated by ligand binding and proteolytic
cleavage, resulting in the release of the Notch intracytoplasmic
domain (NICD). To date, four Notch isoforms have been
described (Tanigaki and Honjo, 2007). Upon translocation to
the nucleus, NICD develops a complex with the DNA recombi-
nant binding protein RBP-Jk, which then loses its repressor
function and initiates transcription (Borggrefe and Oswald,
2009). Direct targets of NICD/RBP-Jk include the Hes and Hey
family of proteins that are transcriptional repressors of
Notch-dependent genes (Iso et al., 2003).
Notch ligands are membrane-bound proteins and Notch
activation links the fate decision of one cell to that of its
neighboring cell through lateral inhibition or inductive interac-
tion (Bray, 2006). The effects of Notch on the maintenance of
stemness or initiation of differentiation are context-dependent
and time-dependent (Androutsellis-Theotokis et al., 2006). The
Notch1 receptor and its ligand Jagged1 are critical components
of the cardiac niche (Boni et al., 2008; Urbanek et al., 2010). In
the neonatal and adult mouse heart, most cardiac niches
contain Notch1-positive CSCs, which are nested in the myocar-
dial interstitium (Fig. 3A and B). The Notch ligand Jagged1 is
expressed in cardiomyocytes and is distributed at the interface
between CSCs and myocytes (Fig. 3C and D). The extracellular
domain of Notch1 is restricted to lineage-negative CSCs,
638 A. Leri et al.which do not express transcription factors and markers of cell
commitment. Importantly, the Notch receptor isoforms
Notch2–4 are present only in ~10% of CSCs (Fig. 3E), pointing
to Notch1 as the major constituent of the Notch pathway in
CSCs within the niches. The expression of the Notch1 receptor
on the plasma membrane in the absence of the nuclear
translocation of its intracellular domain may be linked to a
permissive state in which the multipotentiality of CSCs is
preserved. In contrast, activation of the Notch1 receptor in
CSCs results in upregulation of Nkx2.5, in vitro and in vivo
(Fig. 4A). Activation of the lineage commitment marker Nkx2.5
failed to inhibit cell proliferation. Nuclear co-localization of
Nkx2.5 and Notch1 intra-cellular domain (N1ICD) (Fig. 4B) is
coupled with entry in the cell cycle and enhanced myocyte
formation (Boni et al., 2008; Urbanek et al., 2010). These
observations support the notion that Notch1 regulates theFigure 3 Notch receptors in CSCs. A. LV myocardium at 6 days afte
square is shown at higher magnification in the lower panels. CSCs
recognized by the white fluorescence of α-sarcomeric actin. B. Tw
shown at higher magnification. C. LV myocytes display the Notch liga
inset. D. c-kit-positive CSCs are in contact with myocytes, and Jagg
CSCs (insets, arrowheads). Myocytes are recognized by the white
predominantly the Notch1 receptor isoform. Fraction of ckit-positiv
Notch3 and Notch4. Results are shown as mean ± SD (from Urbanektransition of CSCs from the primitive immature phenotype to
the compartment of amplifyingmyocytes. This cell category has
the ability to divide and simultaneously differentiate.
In stem cell-regulated organs, the pool size of transient
amplifying cells defines the growth reserve of the organ and
its ability to regulate tissue homeostasis and promote the
structural recover following injury (Doupé and Jones, 2012;
Ihrie and Alvarez-Buylla, 2011) Activation of the Notch1
pathway favors the commitment of CSCs to the myocyte
lineage and controls the size of the compartment of
replicating myocytes in vitro and in vivo. This behavior
may correspond to a model of differentiation delay in which
sustained upregulation of Notch1 signaling prolongs the
amplifying state of CSC-derived myocytes and prevents
terminal differentiation and growth arrest. This function of
Notch1 involves the expression of the transcription factorr birth. The CSC, located in the endocardium and included in the
are positive for c-kit (green) and Notch1 (red). Myocytes are
o examples of CSCs positive for c-kit (green) and Notch1 (red)
nd Jagged1 (white). Jagged1 localization is more apparent in the
ed1 is distributed at the interface between cardiomyocytes and
fluorescence of α-sarcomeric actin (α-SA). E. CSCs express
e CSCs expressing the extracellular domains of Notch1, Notch2,
et al., 2010).
Figure 3 (continued).
639Cardiac stem cell nichesNkx2.5, which represents a novel target gene of Notch1, and
drives the acquisition of the myocyte lineage in resident
CSCs.
Notch1 appears to control in part the activation or
repression of the complex transcriptional network that modu-
lates myocyte formation in the adult heart (Boni et al., 2008;
Gude et al., 2008). Interference with cardiomyogenesis by
inhibition of Notch1 has a powerful negative effect on the
anatomy and hemodynamics of the growing heart, resulting in a
dilated cardiomyopathy with high mortality (Fig. 5A–F). The
number of Nkx2.5-positive cells is severely affected, resulting inattenuation in the generation of cardiomyocytes and reduction
of heart weight. The decrease in left ventricular mass was
dictated by a 54% smaller number of cardiomyocytes which
were 55% larger. Following Notch1 inhibition, the number of
capillary profiles per mm2 of myocardium did not decrease as a
result of myocyte hypertrophy, suggesting that the coronary
vasculature grew in proportion to the increase in myocyte size.
Although ~10% of endothelial cells in the coronary vasculature
express the Notch1 receptor, inhibition of this pathway did not
affect their proliferation rate. Importantly, restoration of
cardiomyogenesis by re-establishing Notch1 signaling reverses
the dilatedmyopathy and promotes the recovery of the function
and structure of the myocardium (Urbanek et al., 2010).
Sustained, constitutive activation of Notch1 signaling or
stimulation with the Jagged1 soluble ligand maintains long-
term proliferation of cultured cardiomyocytes, delaying their
differentiation intomature beating cells (Boni et al., 2008). This
phenomenon should not be interpreted as cell dedifferentia-
tion. Activation of the Notch1 receptor does not reprogram
newly formed cardiomyocytes into precursor cells, but prolongs
the proliferative phase of cardiomyocytes, favors their survival
and extends their lifespan. Additionally, N1ICD dictates the
acquisition of the cardiomyocyte phenotype in endothelial
progenitor cells and this response is enhanced by co-culture
with neonatal myocytes secreting Jagged1 (Koyanagi et al.,
2007). These findings strengthen the relevance of N1ICD for
myocyte renewal postnatally. A similar mechanism is operative
in the adult heart after infarction. Activation of the Notch1
receptor is a critical determinant of the transition of adult CSCs
to the compartment of amplifying myocytes, and inhibition
of this pathway has dramatic negative consequences on the
replacement of myocytes and the adaptation of the myocardi-
um to ischemic injury (Boni et al., 2008).
Following myocardial infarction, cardiomyocytes in the
border zone are characterized by marked upregulation of
activated N1ICD, which co-localizes with the nuclear c-Met
receptor (Gude et al., 2008). The expression of the Notch ligand
Jagged1 is significantly increased 4 days after infarction.
Similarly, Delta4 is enhanced in interstitial areas. Injection of
HGF and forced overexpression of activated N1ICD lead to
nuclear accumulation of phosphorylated Akt an improved
ventricular hemodynamics. The integrated and coordinated
activity of the HGF/Notch/c-Met/Akt signaling axis prevents
cell death after ischemia, exerting a cardioprotective effect on
the myocardium.
Myocyte formation (Boni et al., 2008), together with the
increased survival of pre-existingmyocytes (Gude et al., 2008),
decreases infarct size and improves ventricular performance.
Thus, manipulation of Notch activation may have a beneficial
therapeutic impact on the failing post-infarcted heart.Epicardial progenitor cell niches
An alternative source of progenitor cells has been identified in
the epicardium, which represents an epithelial sheet on the
cardiac surface. The contribution of epicardium-derived cells
(EPDCs) to cardiac lineages is a matter of debate. EPDCs
express the transcription factors Wt1, Tbx18, Tcf21, and the
retinoic acid (RA) synthesizing enzyme, Raldh2. The contribu-
tion of EPDCs to coronary vascular smooth muscle cells and
fibroblasts has been carefully documented. In contrast, the
Figure 4 N1ICD overexpression in CSCs promotes the upregulation of myocyte-specific genes. A. Quantitative RT-PCR for target genes of
Notch and cardiovascular genes. Expression is shown as change with respect to CSCs infected with EGFP-lentivirus only. B. CSCs
overexpressing theNotch1 intracellular domain (N1ICD, green) are positive for Nkx2.5 (red) and possess a thin layer ofα-SA (alpha-sarcomeric
actin, white). (From Urbanek et al., 2010).
640 A. Leri et al.role of EPDCs in the formation of the coronary endothelium
and cardiomyocytes is unclear. Initially, the controversy
surrounding the fate of EPDCs was dictated by divergent
findings in chick and mouse studies. More recently, the
disagreement has involved the interpretation of lineage
tracing in cre-loxP-based reporter mouse lines.
Fate mapping studies using Wt1 and Tbx18 Cre lines have
suggested that epicardial progenitors contribute significantly
to the developing myocardium in the mouse (Cai et al., 2008;
Zhou et al., 2008). However, these findings were challenged
based on the observation that Tbx18 is expressed in the
inter-ventricular sulcus and left ventricularmyocardium, even
in epicardium-deficient embryos (Christoffels et al., 2009).
Moreover, the leaky and inefficient recombination detected
in the Wt1 reporter lines and the endogenous endocardial
Wt1 expression has questioned the participation of EPDCs
in cardiomyogenesis (Rudat and Kispert, 2012). These dataemphasize the need to ensure the specificity of Cre-lox based
fate mapping and the rigorous characterization of the native
expression pattern of the gene driving the Cre recombinase.
Clonal assays should be introduced to validate the findings.
In the adult mouse heart, the embryonic epicardial gene
program is downregulated. Following injury, the epicardium
acts as a multipotent cell source and releases trophic factors
that modulate tissue healing, a response characterized by
the reactivation of the embryonic gene program. However,
Wt1 positive sub-epicardial cells form primarily fibroblasts
and a modest number of myocytes that is insufficient for
effective myocardial regeneration (van Wijk et al., 2012).
Recently, a population of epicardially-derived CPCs with
mesenchymal-like properties has been characterized in the
developing and adult mouse heart (Chong et al., 2011). The
documentation of these cells was obtained by introducing the
in vitro colony-forming unit (CFU) assay, which is commonly
Figure 5 Notch inhibition induces a dilated myopathy. A and B. B-mode and M-mode echocardiography of vehicle (left) and
γ-secretase inhibitor (right) injected mice. C and D. γ-secretase inhibition led to ventricular dilation, depressed fractional
shortening, ejection fraction and increased mortality. E. With respect to a control heart (left panel), ventricular dilation and wall
thinning are apparent in γ-secretase inhibitor-treated mice (central and right panels). F. Effects of γ-secretase inhibition on cardiac
anatomy. Results are mean ± SD. *P b 0.05 (from Urbanek et al., 2010).
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642 A. Leri et al.used for the analysis of mesenchymal stem cells (MSCs) in the
bone marrow. Enzymatically dissociated cardiac mononuclear
cells formed colonies in culture composed of fibroid cells
named cardiac CFU-fibroblasts (cCFU-Fs). These cells were
defined as MSCs because of their capacity for clonogenic
propagation, long-term in vitro growth, and multilineage
differentiation. The cCFU-Fs isolated from embryonic and
adult hearts express the MSC markers CD44, CD90, CD29 and
CD105 and the embryonic stem cell markers Oct4 and cMyc.
Additionally, cCFU-Fs are positive for Sca1 and PDGFRα, but
are negative for hematopoietic and endothelial antigens. By
employing fate-mapping strategies, the origin of cCFU-Fs was
meticulously investigated. Mesp1 (mesodermal) and Wnt1
(neural crest) Cre-recombinase lineage tracing assays re-
vealed that cCFU-Fs originate from the mesoderm but not
from the neural crest. Additional lineage tracing studies using
Wt1-Cre and Gata5-Cre epicardial lineage tags found that
cCFU-Fs arise from the proepicardium and epicardium.
Interestingly, the ability of this population to produce
cCFU-Fs appeared to decline in the adult heart. Fate mapping
with Myl2-Cre and Nkx2.5-Cre did not label substantial
numbers of cCFU-Fs, which suggests that they do not arise
from Nkx2.5 cardiac progenitors. This putative stem cell
population occupies a perivascular, adventitial niche adjacent
to coronary arterioles. The relevance of these cells for tissue
homeostasis and repair in vivo remains to be documented.Mesenchymal stem cells
The concept of cooperation between stem cells and
cardiomyocytes, functioning as supporting cells within the
myocardial niches, has been documented carefully. The
interaction between exogenously delivered bone marrow
MSCs and endogenous c-kit-positive CSCs following myocar-
dial infarction has been reported recently (Hatzistergos et
al., 2010). This process combines the regenerative potential
of CSCs with the powerful secretory phenotype of MSCs. The
relatively low efficiency of transdifferentiation of MSCs has
been integrated with their ability to recruit and expand the
local CSC pool and create a large myocyte progeny and
abundant coronary microcirculation. After MSC injection,
chimeric clusters containing MSCs of exogenous origin and
endogenous CSCs develop in the infarcted myocardium and
in the border zone (Fig. 6). CSCs form connexin-43 mediatedFigure 6 Cell–cell interaction between endogenous and exogeno
myocardium are connected to resident c-kit-positive CSCs (red)
resembling stem cell niches (courtesy of Dr. Joshua H. Hare; from Hgap junctions and N-cadherin mechanical connections with
cardiomyocytes and MSCs (Hatzistergos et al., 2010).
Additionally, the remarkable recovery in the anatomical
and functional integrity of the infarctedmyocardium following
combined administration of human MSCs and human c-kit-
positive CSCs (Williams et al., 2013) raises important clinical
questions. Whether the administration of MSCs and CSCs
leads to the formation of temporary and/or permanent
niches within the host myocardium has not been resolved
and constitutes a major challenge for future research (Leri
and Anversa, 2013). The actual transfer of molecules between
MSCs and CSCs remains to be shown to uncover the
fundamental cellular processes involved in the extensive
repair of the damaged heart. However, the “cooperative”
interaction regulating stem cell function may be one of
the most logical outcomes of this complex therapeutic
strategy.
The survival of exogenously administered stem cells
requires their integration with the recipient myocardium.
The region bordering the infarct is exposed to increased wall
stress and functional demand, which promotes myocyte
hypertrophy, activation of interstitial fibroblasts and colla-
gen accumulation. The secretome of the delivered MSCs may
provide an environment favoring the engraftment of CSCs
and the acquisition of the cardiogenic fate.
Hypoxic niches
Stem cell niches in the bone marrow are characterized by low
oxygen tension, a condition that offers a selective advantage to
stem cells favoring their quiescent primitive state (Simsek et
al., 2010; Suda et al., 2011). A similar mechanism may be
operative in the myocardium, and CSC behavior may be
regulated by the O2 gradient within the tissue. The long-term
preservation of the CSC compartment may require a hypoxic
milieu, although physiological normoxia may be necessary for
active cardiomyogenesis. In fact, niches composed of hypoxic
c-kit-positive CSCs have been found throughout the myocardi-
um, although they accumulate preferentially in the atria and
apex of the left ventricle (Sanada et al., 2014). At all ages,
clusters of CSCs with low content of O2 coexist with niches
comprising normoxic CSCs. Hypoxic CSCs are unable to reenter
the cell cycle and divide. By necessity, normoxic CSCs are
forced to undergo intense proliferation and differentiation
with progressive telomere erosion, and formation of senescentus stem cells. A and B. Immature MSCs (green) within the host
by connexin 43 (A, white) and N-cadherin (B, white), closely
atzistergos et al., 2010).
Figure 7 Hypoxic (Pimopos-CSCs) and normoxic (Pimoneg-CSCs) in the young and old myocardium. A–D. Bivariate distribution of
Pimo, Ki67, GATA4 and Nkx2.5 in CSCs from young (A: 3 M) and old (C: 30 M) hearts. Quantitative results in young (B) and old (D) are
shown as mean ± SD. *P b 0.05 vs. Pimopos.
643Cardiac stem cell nichesdysfunctional cardiomyocytes (Rota et al., 2007). Hypoxic
CSCs, particularly in the atria, correspond to quiescent
long-term label retaining cells that rarely divide, while
normoxic CSCs reflect cells that proliferate frequently and
generate a specialized progeny. Additionally, the expression of
the myocyte markers Nkx2.5 and GATA4 is restricted to the
normoxic CSC compartment (Fig. 7A–D). The balance between
these two stem cell classes is critical for the regulation of
myocardial homeostasis and the preservation of the CSC
compartment during the organ lifespan. Aging, however,
expands dramatically the pool of hypoxic quiescent CSCs so
that the smaller pool of cycling CSCs sustains cell turnover.Hypoxic cardiac niches are numerous in the epicardium and
subepicardium of the adult mouse heart (Kimura and Sadek,
2012; Kocabas et al., 2012), which houses a metabolically
distinct population of glycolytic progenitor cells (GPCs). In vivo
perfusion quantification with Hoechst dye has been combined
with metabolic profiling to recognize poorly oxygenated
myocardial areas and cells with low mitochondrial content.
GPCs possess some of the properties of progenitor cells; they
are self-renewing, clonogenic and multipotent. GPCs do not
express c-kit, Sca-1, endothelial and hematopoietic markers
but are positive for the transcription factors Nkx2.5, GATA4,
Wt1, and Tbx18. Themetabolic phenotype of GPCs is regulated
644 A. Leri et al.by HIF-1α. Downregulation of HIF-1α promotes in GPCs a
metabolic shift from glycolysis to mitochondrial oxidative
phosphorylation resulting in a decrease in proliferation with
loss of the primitive state (Kocabas et al., 2012). Similarly,
hypoxic c-kit-positive CSCs showed a lower mitochondrial
activity with respect to normoxic CSCs (Sanada et al., 2014).
Thus, intact functional niches ensure the adequate response of
stem cells to the needs of the organ. Disruption of regenerating
niches may be a critical component of tissue injury, and the
reconstitution of the microenvironment in which stem cells
operate may represent an essential target for the treatment of
myocardial aging and cardiac diseases.Conclusive remarks
Although the utilization of a singlemarker for the identification
of stem cells may be risky, the stem cell antigen c-kit
recognizes a population of CSCs that are self-renewing,
clonogenic and multipotent in vitro and replace necrotic
myocardium with functioning tissue in vivo. It is becoming
apparent that the pool of CSCs is heterogeneous, including
quiescent and actively proliferating cells, migratory and
adherent cells, young and senescent cells, and uncommitted
and early committed cells. A major effort is being made
currently to search for additional surface epitopes able to
identify pools of CSCs with specific properties. The surface
expression of Notch1 recognizes multipotent CSCs, which
are poised for lineage commitment, while the presence of
c-Met and the EphA2 receptor reflect cells with a particular
propensity to migrate out of the niche area. The IGF-1 receptor
is expressed in a compartment of CSCs that can be coaxed to
regenerate large portions of damaged myocardium, while
the IGF-2 receptor is present in CSCs with high susceptibility
to senesce and undergo apoptosis. With the exception of
c-kit-positive CSCs, GPCs and epicardially-derived MSCs, niches
hosting other classes of myocardial progenitors have not been
shown. At present, bioartificial niches are being developed by
introducing nanomaterial, scaffolds and cardiac patches in an
attempt to improve the myocardial recovery after infarction.
The limitations in the healing response of the adult heart,
however, should not be inappropriately interpreted as evi-
dence against CSCs and their role in tissue homeostasis and
regeneration following injury. The recurrent statement made
against the presence of resident CSCs and the significant
growth reserve of the human heart is that spontaneous cardiac
repair does not occur after infarction, and the necrotic tissue is
not restored by intact myocardium (Steinhauser and Lee,
2011); the healing process evolves and a thick scar is formed.
It might come as a surprise, but the lack of endogenous
regeneration after infarction is present in solid and non-solid
organs including the skin, liver, intestine, kidney, and bone
marrow. In all cases, occlusion of a supplying artery leads to
scar formation mimicking cardiac pathology (Anversa et al.,
2013). With polyarteritis nodosa and vasculitis, microinfarcts
develop in the intestine and skin, and resident stem cells do not
restore the damaged tissue. Infarcts of the bone and bone
marrow occur with sickle cell anemia, and HSCs and MSCs do
not reconstitute the structural integrity of the organ. The
simplest example is provided by the occlusion of a branch of a
mesenteric artery; a segmental infarct of the intestine
develops rapidly, and the viable stem cells fail to regeneratethe necrotic tissue, although the stem cells of the crypts renew
the mucosa every ~4 days (Anversa et al., 2013). The stem cell
compartment appears to be properly equipped to regulate
tissue homeostasis but does not respond effectively to ischemic
injury, or late in life to aging and senescence of the organ and
organism.
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